Increased sensitivity to interferon-a in psoriatic T cells

被引:72
作者
Eriksen, KW
Lovato, P
Skov, L
Krejsgaard, T
Kaltoft, K
Geisler, C
Odum, N
机构
[1] Univ Copenhagen, IMMI, Dept Immunol, Inst Mol Biol & Physiol, DK-2200 Copenhagen, Denmark
[2] Gentofte Univ Hosp, Dept Dermatol, Copenhagen, Denmark
[3] Univ Aarhus, Inst Human Genet, Aarhus, Denmark
[4] Univ Copenhagen, Inst Med Microbiol & Immunol, DK-2200 Copenhagen, Denmark
关键词
cytokines; inflammation; signal transduction; skin; T lymphocytes;
D O I
10.1111/j.0022-202X.2005.23864.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Psoriasis is a chronic inflammatory skin disease characterized by abnormal epidermal proliferation. Several studies have shown that skin-infiltrating activated T cells and cytokines play a pivotal role during the initiation and maintenance of the disease. Interferon (IFN)-alpha plays an important role in host defense against infections, but recent data have also implicated IFN-alpha in psoriasis. Thus, IFN-alpha induces or aggravates psoriasis in some patients, and mice lacking a transcriptional attenuator of IFN-alpha/beta signaling spontaneously develop a psoriasis-like inflammatory skin disease characterized by CD8(+)-infiltrating T cells. In this study, we therefore investigate IFN-alpha signaling in T cells isolated from involved skin of psoriatic patients. We show that psoriatic T cells have increased and prolonged responses to IFN-alpha, on the level of signal transducers and activators of transcription (STAT) activation, compared with infiltrating T cells from skin of non-psoriatic donors. Functionally, the increased IFN-alpha signaling leads to an increased binding of STAT4 to the IFN-gamma promotor, IFN-gamma production, and inhibition of T cell growth. In contrast, to STAT responses to other cytokines were not changed in psoriasis. In conclusion, we provide evidence that psoriatic T cells have an increased sensitivity to IFN-alpha. Thus, our data suggest that increased IFN-alpha signaling is involved in the pathogenesis of psoriasis.
引用
收藏
页码:936 / 944
页数:9
相关论文
共 57 条
[1]   The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immuneresponse [J].
Alexander, WS ;
Hilton, DJ .
ANNUAL REVIEW OF IMMUNOLOGY, 2004, 22 :503-529
[2]   The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-γ, interleukin-2, and tumor necrosis factor-α, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations:: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients [J].
Austin, LM ;
Ozawa, M ;
Kikuchi, T ;
Walters, IB ;
Krueger, JG .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (05) :752-759
[3]   UM4D4+ (CDW60) T-CELLS ARE COMPARTMENTALIZED INTO PSORIATIC SKIN AND RELEASE LYMPHOKINES THAT INDUCE A KERATINOCYTE PHENOTYPE EXPRESSED IN PSORIATIC LESIONS [J].
BAADSGAARD, O ;
TONG, P ;
ELDER, JT ;
HANSEN, ER ;
HO, V ;
HAMMERBERG, C ;
LANGEVEJLSGAARD, G ;
FOX, DA ;
FISHER, G ;
CHAN, LS ;
VOORHEES, JJ ;
COOPER, KD .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1990, 95 (03) :275-282
[4]   T-CELL SUBPOPULATIONS IN THE BLOOD AND SKIN OF PATIENTS WITH PSORIASIS [J].
BAKER, BS ;
SWAIN, AF ;
VALDIMARSSON, H ;
FRY, L .
BRITISH JOURNAL OF DERMATOLOGY, 1984, 110 (01) :37-44
[5]   GROWTH INHIBITORY EFFECTS OF INTERFERON ON NORMAL AND MALIGNANT HUMAN HEMATOPOIETIC CELLS [J].
BALKWILL, FR ;
OLIVER, RTD .
INTERNATIONAL JOURNAL OF CANCER, 1977, 20 (04) :500-505
[6]   Cytokines in psoriasis [J].
Bonifati, C ;
Ameglio, F .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1999, 38 (04) :241-251
[7]  
Brassard DL, 2002, J LEUKOCYTE BIOL, V71, P565
[8]  
Brenard R, 1997, ACTA GASTRO-ENT BELG, V60, P211
[9]   Constitutive SOCS-3 expression protects T-cell lymphoma against growth inhibition by IFNα [J].
Brender, C ;
Lovato, P ;
Sommer, VH ;
Woetmann, A ;
Mathiesen, AM ;
Geisler, C ;
Wasik, M ;
Odum, N .
LEUKEMIA, 2005, 19 (02) :209-213
[10]   INTERFERON-ALPHA INCREASES THE FREQUENCY OF INTERFERON-GAMMA-PRODUCING HUMAN CD4+ T-CELLS [J].
BRINKMANN, V ;
GEIGER, T ;
ALKAN, S ;
HEUSSER, CH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (05) :1655-1663